Cargando…
Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned
Background: The current treatment landscape of early stage lung cancer is rapidly evolving, particularly in EGFR mutant non-small cell lung cancer (NSCLC), where target therapy is moving to early stages. In the current review, we collected the available data exploring the impact of EGFR targeting in...
Autores principales: | Belluomini, Lorenzo, Riva, Silvia Teresa, Simbolo, Michele, Nocini, Riccardo, Trestini, Ilaria, Avancini, Alice, Tregnago, Daniela, Ferrara, Miriam Grazia, Caldart, Alberto, Dodi, Alessandra, Caliò, Anna, Bria, Emilio, Scarpa, Aldo, Milella, Michele, Menis, Jessica, Pilotto, Sara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535007/ https://www.ncbi.nlm.nih.gov/pubmed/34685665 http://dx.doi.org/10.3390/cells10102685 |
Ejemplares similares
-
Body composition as a modulator of response to immunotherapy in lung cancer: time to deal with it
por: Trestini, I., et al.
Publicado: (2021) -
Infections and Immunotherapy in Lung Cancer: A Bad Relationship?
por: Belluomini, Lorenzo, et al.
Publicado: (2020) -
A narrative review on tumor microenvironment in oligometastatic and oligoprogressive non-small cell lung cancer: a lot remains to be done
por: Belluomini, Lorenzo, et al.
Publicado: (2021) -
Adjuvant Targeted Therapy in Solid Cancers: Pioneers and New Glories
por: Sposito, Marco, et al.
Publicado: (2023) -
Willingness, preferences, barriers, and facilitators of a multimodal supportive care intervention including exercise, nutritional and psychological approach in patients with cancer: a cross-sectional study
por: Avancini, Alice, et al.
Publicado: (2022)